Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials (Q46670494)
Jump to navigation
Jump to search
scientific article published in January 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials |
scientific article published in January 2006 |
Statements
1 reference
Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials (English)
1 reference
Caryn Lerman
1 reference
Christopher Jepson
1 reference
E Paul Wileyto
1 reference
Leonard H Epstein
1 reference
Margaret Rukstalis
1 reference
Freda Patterson
1 reference
Vyga Kaufmann
1 reference
Stephanie Restine
1 reference
Larry Hawk
1 reference
Ray Niaura
1 reference
Wade Berrettini
1 reference
1 January 2006
1 reference
1 reference
31
1 reference
231-242
1 reference
1
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference